Cryoport Inc
CYRX
查看詳細走勢圖
9.740USD
-0.010-0.10%
收盤 12/23, 16:00（美東）報價延遲15分鐘
487.67M總市值
7.73本益比TTM
盤中分時
1分
30分
1小時
日k
週k
月k
日k
今天
-0.10%
5天
+5.41%
1月
+10.93%
6月
+52.90%
今年開始到現在
+25.19%
1年
+23.92%
查看詳細走勢圖
TradingKey Cryoport Inc股票評分
單位: USD 更新時間: 2025-12-22操作建議
Cryoport Inc當前公司基本面數據相對非常健康，增長潛力較大。當前估值合理，在貨運與物流服務行業排名33/74位。機構持股佔比非常高，近一個月多位分析師給出公司評級為買入。最高目標價13.22。中期看，股價處於平穩狀態。近一個月，市場表現一般，但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間，可以做區間波段操作。
Cryoport Inc評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
9
分析師
買入
評級
13.222
目標均價
+38.31%
漲幅空間
數據免責聲明：分析師評級與目標價由LSEG提供，僅供參考，不應當作投資建議
Cryoport Inc亮點
亮點風險
Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.
利潤高增長
公司淨利潤處於行業前列，最新年度總收入228.38M美元
估值合理
公司最新PB估值1.03，處於3年歷史合理位
PRFDX持倉
明星投資者PRFDX持倉，最新持倉7.95K股
活躍度增加
近期活躍度增加，過去20天平均換手率0.90
Cryoport Inc新聞
即將為您帶來更多新聞，敬請期待。 。 。
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Cryoport Inc簡介
Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.
公司代碼CYRX
公司Cryoport Inc
CEOShelton (Jerrell Wilson)
網址https://www.cryoport.com/
常見問題
Cryoport Inc(CYRX)的當前股價是多少？
Cryoport Inc(CYRX)的當前股價是 9.740。
Cryoport Inc 的股票代碼是什麼？
Cryoport Inc的股票代碼是CYRX。
Cryoport Inc股票的52週最高點是多少？
Cryoport Inc股票的52週最高點是11.440。
Cryoport Inc股票的52週最低點是多少？
Cryoport Inc股票的52週最低點是4.580。
Cryoport Inc的市值是多少？
Cryoport Inc的市值是487.67M。
Cryoport Inc的淨利潤是多少？
Cryoport Inc的淨利潤為-122.76M。
現在Cryoport Inc(CYRX)的股票是買入、持有還是賣出？
根據分析師評級，Cryoport Inc(CYRX)的總體評級為買入，目標價格為13.222。
Cryoport Inc(CYRX)股票的每股收益（EPS TTM）是多少
Cryoport Inc(CYRX)股票的每股收益（EPS TTM）是1.260。
相關品種
-0.20%
-0.54%
+0.80%
+0.14%
-0.04%
+0.06%
+0.55%
-2.18%
-0.44%
-2.15%
-0.43%
-1.61%
-0.84%
-0.24%
-1.28%
-0.85%
-1.37%
+0.85%
+1.56%
-4.06%
